Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Next-generation sequencing (NGS) data are used for both clinical care and clinical research. DNA sequence variants identified using NGS are often returned to patients/participants as part of clinical or research protocols. The current standard of care is to validate NGS variants using Sanger sequencing, which is costly and time-consuming. METHODS: We performed a large-scale, systematic evaluation of Sanger-based validation of NGS variants using data from the ClinSeq® project. We first used NGS data from 19 genes in 5 participants, comparing them to high-throughput Sanger sequencing results on the same samples, and found no discrepancies among 234 NGS variants. We then compared NGS variants in 5 genes from 684 participants against data from Sanger sequencing. RESULTS: Of over 5800 NGS-derived variants, 19 were not validated by Sanger data. Using newly designed sequencing primers, Sanger sequencing confirmed 17 of the NGS variants, and the remaining 2 variants had low quality scores from exome sequencing. Overall, we measured a validation rate of 99.965% for NGS variants using Sanger sequencing, which was higher than many existing medical tests that do not necessitate orthogonal validation. CONCLUSIONS: A single round of Sanger sequencing is more likely to incorrectly refute a true-positive variant from NGS than to correctly identify a false-positive variant from NGS. Validation of NGS-derived variants using Sanger sequencing has limited utility, and best practice standards should not include routine orthogonal Sanger validation of NGS variants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE DISTRIBUTION OF THE FLORA IN THE ALPINE ZONE. 1
Jaccard, P. (1912) · New Phytologist · doi:10.1111/j.1469-8137.1912.tb05611.x · Cited by 4,561
Individualized Iterative Phenotyping for Genome-wide Analysis of Loss-of-Function Mutations
Johnston, J. J., Lewis, K. L., Ng, D., Singh, L. N., Wynter, J., Brewer, C., Brooks, B. P., Brownell, I., Candotti, F., Gonsalves, S. G., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.04.013 · Cited by 67
Self-citation
Cited by
Paediatric genomics: diagnosing rare disease in children
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.116 · Cited by 618
An open resource for accurately benchmarking small variant and reference calls
Zook, J. M., McDaniel, J., Olson, N. D., Wagner, J., Parikh, H., Heaton, H., Irvine, S. A., Trigg, L., Truty, R., McLean, C. Y., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0074-6 · Cited by 399
Best practices for variant calling in clinical sequencing
Koboldt, D. C. (2020) · Genome Medicine · doi:10.1186/s13073-020-00791-w · Cited by 384
A Sequel to Sanger: amplicon sequencing that scales
Hebert, P. D. N., Braukmann, T. W. A., Prosser, S. W. J., Ratnasingham, S., deWaard, J. R., Ivanova, N. V., Janzen, D. H., Hallwachs, W., Naik, S., Sones, J. E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4611-3 · Cited by 280
Tracy: basecalling, alignment, assembly and deconvolution of sanger chromatogram trace files
Rausch, T., Fritz, M. H.-Y., Untergasser, A., & Benes, V. (2020) · BMC Genomics · doi:10.1186/s12864-020-6635-8 · Cited by 130
Genome-wide sequencing in acutely ill infants: genomic medicine’s critical application?
Friedman, J. M., Bombard, Y., Cornel, M. C., Fernandez, C. V., Junker, A. K., Plon, S. E., Stark, Z., & Knoppers, B. M. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0055-z · Cited by 44
Metadata
- Authors
- Beck, T. F., Mullikin, J. C., Program, T. N. C. S., & Biesecker, L. G.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-04-01
- Volume
- 62
- Issue
- 4
- Pages
- 647-654
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2299670551
- Cited by
- 207
- References
- 2
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.